Glenmark initiates Phase IIb dose range finding study
The study will evaluate safety and efficacy of GRC 27864 in patients with moderate osteoarthritic pain
Author
Intas acquires generics business of Actavis in UK, Ireland
This acquisition is set to more than double Intas' pan-European operations, with pro-forma revenues exceeding $500 million
Livongo and Lilly collaborate on real-world diabetes research
Companies join forces to advance predictive and prescriptive recommendations for people with diabetes
Eisai set-ups new OSD production facility in China
Operations are expected to commence in the second half of fiscal 2018
EU approves AstraZeneca’s Fasenra
Fasenra is comapany's first respiratory biologic medicine for severe eosinophilic asthma
Biogen and Eisai promote multiple sclerosis treatments in Japan
Based on the agreement two companies will jointly conduct promotional activities at the clinical facilities
Novartis appoints Elizabeth Barrett as oncology head
Barrett currently is Global President Oncology at Pfizer
Ministry of AYUSH welcomes Traditional Systems of Medicine and Homeopathy initiatives from Malaysia
5th Bilateral Meeting was presided by Pramod Kumar Pathak, Joint Secretary, Ministry of AYUSH from Indian side and Deputy Director…